Drug profile

The FDA adverse-event record for Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C And D-Moraxella Bovis Bacterin-Toxoid

11 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C And D-Moraxella Bovis Bacterin-Toxoid. See the species affected, top reactions, and outcomes below.

11
adverse-event reports
72.7%
death-coded share
Cattle
most-reported species
7
Death - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
11
Total Reports
8
Deaths Reported
72.7%
Death Rate

Active Ingredients

Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C And D-Moraxella Bovis Bacterin-Toxoid

Administration Routes

SubcutaneousUnknown

Species Affected

Cattle 11

Most Affected Breeds

Cattle (other) 5
Cattle (unknown) 2
Crossbred Bovine/Cattle 2
Holstein-Friesian also known as Holstein 1
Aberdeen Angus 1

Most Reported Reactions

Death 7
NT - Abnormal necropsy finding NOS 3
INEFFECTIVE, PARASITE(S) NOS 2
Pink eye 2
Anorexia 2
Other abnormal test result NOS 2
Diarrhoea 1
Increased respiratory rate 1
Rhinitis 1
Weight loss 1
Ocular discharge 1
Lack of efficacy - NOS 1

Outcome Breakdown

Died
8 (47.1%)
Recovered/Normal
4 (23.5%)
Outcome Unknown
3 (17.6%)
Ongoing
1 (5.9%)
Recovered with Sequela
1 (5.9%)

Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C And D-Moraxella Bovis Bacterin-Toxoid Adverse Event Insights

11 reports name Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C And D-Moraxella Bovis Bacterin-Toxoid; 8 recorded a death outcome (72.7% of reported events, not a population-level mortality rate). Active ingredient: Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C And D-Moraxella Bovis Bacterin-Toxoid. Administration routes: Subcutaneous, Unknown.

By species: Cattle (11 reports). By breed: Cattle (other) (5), Cattle (unknown) (2), Crossbred Bovine/Cattle (2).

Leading clinical signs: Death (7), NT - Abnormal necropsy finding NOS (3), INEFFECTIVE, PARASITE(S) NOS (2), Pink eye (2). Outcome, 17 coded reports: Died leads at 47.1%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.